Literature DB >> 32235629

Type 2 Diabetes Mellitus Related Distress in Thailand.

Kongprai Tunsuchart1, Peerasak Lerttrakarnnon2, Kriengkrai Srithanaviboonchai1,3, Surinporn Likhitsathian4, Sombat Skulphan5.   

Abstract

This study aimed to investigate prevalence and factors potentially associated with diabetes-related distress (DRD) among type 2 diabetes mellitus (T2DM) patients in a primary health care center in Thailand. This cross-sectional study was conducted with a total of 370 patients with T2DM. Data were collected at primary health care centers in Hang Dong District, Chiang Mai Province, Thailand. DRD was assessed using the Diabetes Distress Scale (DDS-17). The association between sociodemographic characteristics and other factors with DRD was analyzed using the Fisher t-test, Chi-square test, and Pearson's correlation coefficient test. The association between Hemoglobin A1c (HbA1c) and DRD was analyzed using multiple linear regression analysis. The participants had a mean age of 60.95 ± 7.96, and most were female (68.1%). Of the participants with DRD, 8.9% had moderate to high levels of distress. Education level and family support were significantly associated with the overall level of DRD. Additionally, HbA1c and co-morbidity were also significantly associated with DRD, as were emotional burden and regimen distress. Multiple linear regression analysis found that increased HbA1c was positively associated with increased DRD after adjusting for age, sex, education, duration of T2DM, co-morbidity, diabetic complications, and family support. Screening with DRD may be beneficial in T2DM patients.

Entities:  

Keywords:  diabetes-related distress (DRD); primary care; type 2 diabetes mellitus

Year:  2020        PMID: 32235629      PMCID: PMC7177402          DOI: 10.3390/ijerph17072329

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


1. Introduction

Diabetes mellitus (DM) is a chronic disease, and one of the most common metabolic disorders globally. The International Diabetes Federation (IDF) reported in 2019 that 436 million adults were living with diabetes around the world, and that this number was projected to increase to 700 million by 2045 [1]. Approximately 90% of the total were type 2 DM (T2DM) [1]. Thailand has the seventh largest diabetic patient population in the Western Pacific [2], with a prevalence of 9.9% in the adult population [3]. Diabetes is a leading cause of death in Thailand. Of the more than 200,000 deaths annually due to chronic non-communicable diseases in Thailand, approximately 30,000 (15%) are due to diabetes [4]. Diabetes mellitus is a condition in which the body has high blood sugar levels (hyperglycemia) due to a lack of insulin hormones, impaired secretion of insulin, or both [5]. Prolonged high blood sugar levels can result in the destruction, deterioration, and failure of vital organs [6]. Inability to control blood sugar levels can result from both non-modifiable factors and from modifiable factors. Non-modifiable factors include gender, age, duration of diabetes, microvascular and macrovascular complications, and comorbidity [7,8]. Modifiable factors include behavioral and/or psychosocial issues, e.g., incorrect eating habits, not exercising, obesity or high body mass index, not consulting with a doctor, and not taking medication as prescribed by a doctor [9,10,11,12,13], as well as stress, depression and anxiety [14,15], especially diabetes-related distress [16,17,18]. Diabetes-related distress (DRD) is a syndrome comprised of multidimensional components including worry, conflict, frustration, and discouragement that can accompany living with diabetes. Negative physical and psychological effects can be directly attributable to long-term suffering from diabetes-related emotional distress [19,20]. Sixty percent of patients with diabetes who have high levels of negative mood and/or psychological distress display a high level of distress [21]. Previous studies have reported a high prevalence of DRD in individuals with T2DM, e.g., the prevalence was 64% in China [22], 63.7% in Iran [23], 49.2% in Malaysia [24], and 48.5% in Bangladesh [25]. Moreover, previous studies have reported that long-term DRD in diabetic patients is associated with anxiety [26], depression [22,27,28,29], low levels of physical activity [18], obesity [28], low medication compliance [30,31], poor diet control, low self-efficacy [32], poor self-care behavior [21], and poor quality of life [33]. A high level of DRD has also been shown to be associated with high HbA1c levels [17,18,30]. Furthermore, the bidirectional association between chronic physical diseases (CPD) and psychopathological factors might lead to an exacerbation of both conditions [34]. Most clinicians are aware that emotional distress is common among their patients with diabetes and that this distress has a deleterious effect on diabetes outcomes; however, many clinicians feel unable to treat this distress [35]. Nevertheless, the health consequences of emotional problems are associated with poor self-care behavior, poor metabolic outcomes, morbidity, mortality, functional limitations, and reduced quality of life [35]. These negative effects are not limited to diagnosable psychiatric disorders [21]. Thus, addressing these emotional problems is key to successful health care intervention, even if diabetes self-care is adequate [35]. For that reason, DRD screening is an important first step in the treatment of mental health problems of patients with T2DM. In Thailand, there have been few studies of the prevalence of DRD and factors associated with DRD in T2DM. This study aimed to investigate prevalence and factors associated with DRD among T2DM.

2. Materials and Methods

2.1. Study Design, Population

This cross-sectional study of 370 respondents from a total DM population of 3894 in Hang Dong District, Chiang Mai Province, Thailand, was conducted between January and March 2017 at thirteen primary health care centers in Hang Dong District. Inclusion criteria were being a patient with type 2 DM, aged 18 years or above. Exclusion criteria were inability to communicate in the Thai language, communication disorder, a history of psychiatric disorders, Alzheimer’s disease, and dementia. Respondents were chosen by simple random sampling. Sample size was calculated using the n4Studies application for estimating the proportion of a finite population [25] and was based on the 48.5% of DRD; delta = 0.05, alpha = 0.05, Z (0.975) = 1.960 patients in the study area eligible for inclusion in the analysis [36]. The formula is defined follow:

2.2. Data Collection and Diabetes-Related Distress Level Measurement

Respondents were recruited into the study after providing written informed consent. All subjects were interviewed to obtain demographic information (age, sex, marital status, education, occupation, family support, and medical history (diabetic complications, co-morbidity, duration of DM, type of diabetic management, HbA1c level). The Diabetes Distress Scale (DDS-17) questionnaire for assessing DRD developed by Polonsky et al. [37] was translated into the Thai language by Kattika [20]. The alpha coefficient of the questionnaire was 0.95. The questionnaire is composed of 17 items grouped in four sub-components: five items about emotional burden (EB), three items about regimen-related distress (RD), three items about interpersonal-related distress (ID), and four items about physician-related distress (PD). Each item is rated on a 6-point scale from 1 (no problem) to 6 (serious problems). Sub-components were interpreted as the mean score of the sub-component: <2 = little or no distress, 2–2.9 = moderate distress, and ≥3 = a high level of distress.

2.3. Statistical Analysis

Descriptive statistics are reported as frequencies, means, and standard deviations. The associations between sociodemographic characteristics, potentially related factors, and DRD were analyzed using the Fisher t-test, Chi-square test, and Pearson’s correlation coefficient test. The association between HbA1c level and DRD was analyzed using multiple linear regression analysis.

2.4. Ethical Considerations

The study was approved by the Research Ethics Committee of the Faculty of Medicine, Chiang Mai University, Thailand (REF: COM-2016-05965).

3. Results

The average age of respondents was 60.95 years (±7.96); most were female (68.1%), married (69.8%), had at least some formal education (90.8%), were currently employed (69.7%). A family member was the primary caretaker in most cases (76.8%). Most of the patients had complications (84.9%) and comorbidity (81.9%). An average duration of T2DM was 9.17 ± 6.46 years. The most frequent treatment method was medication (95.1%). The mean HbA1c level was 8.02 ± 1.55% (Table 1).
Table 1

Demographics characteristics of respondents (n = 370).

Characteristics (mean ± SD) Clinical Sample n (%)
Age (years) (60.95 ± 7.96)
 <60157 (42.4%)
 ≥60213 (57.6%)
Sex
 Male188 (31.9%)
 Female252 (68.1%)
Marital status
 Single22 (5.9%)
 Married258 (69.8%)
 Separated/Widowed90 (24.3%)
Education
 None34 (9.2%)
 Some formal education336 (90.8%)
Occupation
 Unemployed112 (30.3%)
 Employed258 (69.7%)
Family support
 No86 (23.2%)
 Yes284 (76.8%)
Diabetic complications
 Absent56 (15.1%)
 Present314 (84.9%)
Co-morbidity
 Absent67 (18.1%)
 Present303 (81.9%)
Duration of T2DM (years) (9.17 ± 6.46)
 0–10256 (69.2%)
 >10114 (30.8%)
Type of diabetes management
 Lifestyle modification7 (1.9%)
 Oral hypoglycemic drugs352 (95.1%)
 Insulin use7 (1.9%)
 Insulin plus oral hypoglycemic drugs4 (1.1%)
HbA1c (%) (8.02 ± 1.55)
 Good <790 (24.3%)
 Fair 7–8113 (30.5%)
 Poor >8167 (45.1%)
Of the DRD cases identified by DDS-17, 1.1% were found to be at a high level, 7.8% at a moderate level, and 91.1% at a mild level. The EB sub-component had the greatest moderate or high level of DRD (27.1%). Physician-related distress had the least moderate plus high level of DRD (4.3%) (Table 2).
Table 2

Diabetes-related Distress of respondents (n = 370) by Diabetes Distress Scale (DDS)-17 level.

Domain of DistressLevel of Diabetes-Related Distress n (%)
Non or MildModerateHigh
Emotional burden (EB)270 (73.0%)82 (22.2%)18 (4.9%)
Physician-related distress (PD)354 (95.7%)14 (3.8%)2 (0.5%)
Regimen-related distress (RD)313 (84.6%)50 (13.5%)7 (1.9%)
Diabetes-related interpersonal distress (ID)324 (87.6%)36 (9.7%)10 (2.7%)
Total diabetes-related distress337 (91.1%)29 (7.8%)4 (1.1%)
This study found that education (p < 0.05) and family support (p < 0.05) were significantly associated with the level of total diabetes-related distress. However, age, sex, marital status, occupation, diabetic complications, co-morbidity, duration of DM, type of diabetic management, and HbA1c were not significantly associated with the level of total DRD (Table 3).
Table 3

Sociodemographic of respondents and level of diabetes distress (n = 370).

CharacteristicsLevel of Total Diabetes-Related Distress (%)p-Value
Non or MildModerateHigh
Age, mean ± SD60.9 ± 8.361.0 ± 5.765.0 ± 4.4
 <60146 (43.3)11 (37.9)0 (0.0)0.192
 ≥60191 (56.7)18 (62.1)4 (100.0)
Sexb
 Male108 (32.0)10 (34.5)0(0.0)0.374
 Female229 (68.0)19 (65.5)4 (100.0)
Marital status
 Married238 (70.6)19 (65.5)2 (50.0)0.630
 Single20 (5.9)19 (3.4)0 (0.0)
 Separated/Widowed79 (23.4)9 (31.0)2 (50.0)
Education
 None26 (7.7)7 (24.1)1 (25.0)0.007 **
 Some formal education311 (92.3)22 (75.9)3 (75.0)
Occupation
 Unemployed99 (29.4)10 (34.5)3 (75.0)0.125
 Employed238 (70.6)19 (65.5)1 (25.0)
Family support
 No78 (23.1)5 (17.2)3 (75.0)0.037 *
 Yes259 (76.9)24 (82.8)1 (25.0)
Diabetic complications
 Absent60 (17.8)7 (24.1)0 (0.0)0.446
 Present277 (82.2)22 (75.9)4 (100.0)
Co-morbidity
 Absent52 (15.4)3 (10.3)1 (25.0)0.656
 Present285 (84.6)26 (89.7)3 (75.0)
Duration of T2DM (in years)
 0–10236 (70.0)17 (58.6)3 (75.0)0.429
 >10101 (30.0)12 (41.4)1 (25.0)
Type of diabetic management
 Lifestyle modification7 (2.1)0 (0.0)0 (0.0)0.504
 Oral hypoglycemic drugs321 (95.3)27 (93.1)4 (100.0)
 Insulin5 (1.5)2 (6.9)0 (0.0)
 Insulin and oral hypoglycemic drugs4 (1.2)0 (0.0)0 (0.0)
HbA1c
 Good (<7)82 (24.3)7 (24.1)1 (25.0)0.764
 Fair (7–8)100 (29.7)11 (37.9)2 (50.0)
 Poor (>8)155 (46.0)11 (37.9)1 (25.0)

Fisher t-test; * p < 0.05, ** p < 0.01.

The study found that HbA1c and co-morbidity were significantly associated with total DRD, EB, and RD. However, HbA1c and co-morbidity were not significantly associated with PD or ID. In addition, age and duration of DM were not significantly associated with total DRD, EB, PD, RD, or ID. (Table 4)
Table 4

Association between diabetes-related distress and potentially related factors (n = 370).

CharacteristicTotal DRDEBPDRDID
Age0.8910.6820.7040.5830.199
Duration of T2DM (in years)0.2330.1210.5360.4640.165
HbA1c0.023 *0.029 *0.5860.011 *0.234
Co-morbidity0.043 *0.015 *0.1190.011 *0.212

Pearson’s correlation coefficient; * p < 0.05 = statistically significant.

Multiple linear regression analysis found that higher HbA1c level was positively associated with increasing greater diabetes-related distress after adjusting for age, sex, education, duration of DM, co-morbidity, diabetic complications, and family support (Table 5).
Table 5

Association between Hemoglobin A1c (HbA1c) and diabetes-related distress, using multiple linear regression analysis.

CharacteristicsRegression CoefficientSEp-Value
HbA1c0.6450.3000.032
Age−0.0150.0510.769
Sex−0.9010.8480.289
Education−0.5860.6290.352
Duration of T2DM (year)0.0160.0630.800
Co-morbidity0.8190.4260.055
Diabetic complications1.4151.0500.179
Family support−1.3560.9120.138

Adjust for age, sex, education, duration of DM, co-morbidity, diabetic complications, family care.

4. Discussion

This study aimed to assess prevalence of DRD, and factors potentially associated with T2DM at the primary care level. Prevalence of DRD from DDS-17 was 8.9%, of which 1.1% was at the high level and 7.8% at the moderate level. That is lower than other studies, e.g., the prevalence of DRD was 49.2% in Malaysia [24], 48.5% in Bangladesh [25], 42.15% in China [38], 51.3% in the US [16], and 63.7% in Iran [23]. Conversely, a study in Germany conducted at a tertiary care facility reported the prevalence of DRD was 8.9% using the Problem Area in Diabetes (PAID) questionnaire, the same level found in this study. However, another German study conducted at the primary care level reported only a 1.2% prevalence of DRD using the PAID scale [39,40]. The differences in DRD prevalence might result from differences in the assessment tools, i.e., the PAID and the DDS-17 questionnaires, which could potentially affect prevalence, e.g., sample size, access to health care, care setting [39], and demographic variables, e.g., education level and family support, as well as health status, e.g., HbA1c level, and co-morbidity [24,41,42]. The findings of these studies are consistent with our finding that DRD prevalence is higher in people with type 2 diabetes treated in a secondary and tertiary care setting than in those treated in a primary care setting [39,43]. Our study found that education level and family support were both significantly associated with the level of total diabetes-related distress (p = 0.007 and p = 0.037, respectively). A previous study reported that the major predictor for high diabetes distress scores among diabetic cases was low education level [44]. That association may be the result of low education leading to poor knowledge about the illness and its complications, which, in turn, increases the risk of poor dietary habits, poor medication compliance, and fewer health check-ups. Another study found lack of supportive family behavior was positively associated with emotional distress [45]. When family members behave negatively, e.g., by nagging or criticizing specific health-related behaviors, people with type 2 diabetes may respond by perceiving higher levels of diabetes-related distress. However, age, sex, marital status, occupation, diabetic complications, presence of co-morbidity, duration of DM, type of diabetic management, and HbA1c level (good, fair, poor) were not significantly associated with the level of total diabetes-related distress. The results of the present study are consistent with those of Zhou et al., which reported that the total DDS score was not significantly related to patients’ gender, age, diabetes duration, diabetes education, or complications [38]. On the other hand, other studies have reported that DRD is associated with age, duration of diabetes, occupation, marital status, glycemic status, treatment modalities, comorbidity, and diabetic complications [25,41,42]. These findings suggest that there may be other factors which affect DRD, e.g., type of diabetes, treatment regimen, and socioeconomic factors [21]. Total DRD, EB, and RD were found to be associated with both HbA1C and co-morbidity. EB includes a variety of negative emotions such as despair, conflict and fear-induced anger that result from thinking about the prospect of a lifetime of living with diabetes, and feeling overwhelmed by the many resulting demands [20]. Type D personality [46] and alexithymia [47] have been reported to adversely affect outcomes in patients with T2DM. However, our study did not attempt to identify those personality traits in the respondents. Further assessment of T2DM patients is needed to identify these personality traits in patients, and to measure the emotional burden they create. Appropriate emotional management of the EB dimension could assist in the control of blood sugar level [47]. RD encompasses concerns and discouragement that patients perceive and/or encounter while trying to self-manage their disease [20]. Integration of compliance, adherence, concordance, self-management, and empowerment could potentially improve medical approaches for RD patients [48]. In addition, age and duration of DM were not significantly associated with DRD, EB, PD, RD, or ID. Previous studies have reported that DRD is associated with HbA1c [42], that EB is associated with high HbA1c levels [49], and that RD is associated with high HbA1c values in hospital [50]. The present study found that both HbA1c and co-morbidity are associated with DRD. Multiple linear regression analysis found that higher HbA1c level is positively associated with increased diabetes-related distress after adjusting age, sex, education, duration of DM, co-morbidity, diabetic complications, and family support. These findings are consistent with a study by Tsujii et al. [17] that showed the association between glycemic control and diabetes distress among Japanese patients with type 2 diabetes. That study found diabetes distress was significantly associated with higher HbA1c levels. The relative risk for poor glycemic control (HbA1c ≥ 64 mmol⁄mol) was 8.0% when adjusted for age, sex, BMI, type of diabetes therapy, and duration of diabetes. A longitudinal study by Fisher et al. found the effect of diabetes distress in adults with type 2 diabetes that HbA1c was positively correlated with DRD [26]. Another study by Fisher et al., of the pattern of relationships between diabetic patients, used the DDS-17 to create a cut score for suffering among patients with type 2 diabetes. They found a consistent curvilinear relationship between the DDS and HbA1c [32]. A study by Tol et al., which assessed diabetes distress and related factors among type 2 diabetic patients to better tailor intervention planning in Isfahan, Iran, found diabetes-related distress in type 2 diabetic patients had a direct linear relation with HbAlc (r = 0.63, p < 0.001) [42]. Nanayakkara et al. explored the prevalence of, and factors associated with, diabetes distress in adults with type 2 diabetes in Australia. That study found diabetes distress was associated with higher HbA1c [50]. In addition, previous studies report psychological changes that occur with people with DM, which can have a significant impact on metabolic control. One of the major obstacles in this area is the need for a better understanding of psychological changes and their influence on changes in blood sugar levels [51]. Strengths of the present study include the use of a validated Thai language DDS-17 and an adequate sample size. A limitation of the study is that it was cross-sectional. Future studies should use a cohort methodology to confirm the causal relationship between HbA1c and DRD. Diseases were not classified in variables including complication and co-morbidity, which were confounding factors. Future studies should have the classification of co-morbidity and complication in order to control confounding factors which can affect DRD.

5. Conclusions

The prevalence of DRD is low at the primary care level. Education and family support are associated with DRD level. HbA1c level and co-morbidity are associated with the emotional burden and regimen-related distress sub-components of DRD. Screening with DRD may be beneficial in T2DM patients for reducing emotional problems, especially in patients with a low education level and patients with little or no family support. Further DRD studies should be conducted in secondary care and tertiary care settings.
  45 in total

1.  Self-rated diabetes control in a Canadian population with type 2 diabetes: associations with health behaviours and outcomes.

Authors:  Kimberley J Smith; Véronique Pagé; Geneviève Gariépy; Mélanie Béland; Ghislaine Badawi; Norbert Schmitz
Journal:  Diabetes Res Clin Pract       Date:  2011-11-08       Impact factor: 5.602

2.  Association between diabetes self-care, medication adherence, anxiety, depression, and glycemic control in type 2 diabetes.

Authors:  Ayman A Al-Hayek; Asirvatham A Robert; Aus A Alzaid; Hussam M Nusair; Nariman S Zbaidi; Muwafak H Al-Eithan; Asirvatham E Sam
Journal:  Saudi Med J       Date:  2012-06       Impact factor: 1.484

3.  Standards of medical care in diabetes--2015: summary of revisions.

Authors: 
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

4.  Psychological problems in patients with type 2 diabetes--clinical considerations.

Authors:  Zana Stanković; Miroslava Jasović-Gasić; Dusica Lecić-Tosevski
Journal:  Vojnosanit Pregl       Date:  2013-12       Impact factor: 0.168

Review 5.  The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision.

Authors:  L Fisher; J S Gonzalez; W H Polonsky
Journal:  Diabet Med       Date:  2014-07       Impact factor: 4.359

6.  Disease-related distress, self-care and clinical outcomes among low-income patients with diabetes.

Authors:  Anjali U Pandit; Stacy C Bailey; Laura M Curtis; Hilary K Seligman; Terry C Davis; Ruth M Parker; Dean Schillinger; Darren DeWalt; David Fleming; David C Mohr; Michael S Wolf
Journal:  J Epidemiol Community Health       Date:  2014-01-31       Impact factor: 3.710

7.  Diabetes-Related Burden and Distress is Low in People with Diabetes at Outpatient Tertiary Care Level.

Authors:  N Kuniss; G Kramer; N Müller; C Kloos; T Lehmann; S Lorkowski; G Wolf; U A Müller
Journal:  Exp Clin Endocrinol Diabetes       Date:  2016-05-24       Impact factor: 2.949

8.  Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses.

Authors:  Lawrence Fisher; Joseph T Mullan; Patricia Arean; Russell E Glasgow; Danielle Hessler; Umesh Masharani
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

9.  Assessment of diabetic distress and disease related factors in patients with type 2 diabetes in Isfahan: A way to tailor an effective intervention planning in Isfahan-Iran.

Authors:  Azar Tol; Abdolvahab Baghbanian; Golamreza Sharifirad; Davoud Shojaeizadeh; Ahmadali Eslami; Fatemeh Alhani; Mohamadreza Mohajeri Tehrani
Journal:  J Diabetes Metab Disord       Date:  2012-10-17

10.  Diabetes-Related Distress Assessment among Type 2 Diabetes Patients.

Authors:  Majed O Aljuaid; Abdulmajeed M Almutairi; Mohammed A Assiri; Dhifallah M Almalki; Khaled Alswat
Journal:  J Diabetes Res       Date:  2018-03-26       Impact factor: 4.011

View more
  7 in total

1.  Prevalence of Diabetes Related Distress and Associated Factors Among Type 2 Diabetes Patients Attending Hospitals, Southwest Ethiopia, 2020: A Cross-Sectional Study.

Authors:  Bonsa Amsalu Geleta; Sanbato Tamiru Dingata; Milkias Dugassa Emanu; Lemi Bacha Eba; Kebebe Bidira Abera; Dereje Tsegaye
Journal:  Patient Relat Outcome Meas       Date:  2021-01-26

2.  Diabetes-Related Distress and Its Associated Factors Among Patients with Diabetes in Vietnam.

Authors:  Van Bang Nguyen; Tam Thi Tran; Thi Ly Dang; Van Vy Hau Nguyen; Binh Thang Tran; Chi Van Le; Nguyen Dinh Toan
Journal:  Psychol Res Behav Manag       Date:  2020-12-14

3.  An Empirical Study on Diabetes Depression over Distress Evaluation Using Diagnosis Statistical Manual and Chi-Square Method.

Authors:  Sohail M Noman; Jehangir Arshad; Muhammad Zeeshan; Ateeq Ur Rehman; Amir Haider; Shahzada Khurram; Omar Cheikhrouhou; Habib Hamam; Muhammad Shafiq
Journal:  Int J Environ Res Public Health       Date:  2021-04-03       Impact factor: 3.390

4.  Process evaluation protocol of a cluster randomised trial for a scalable solution for delivery of Diabetes Self-Management Education in Thailand (DSME-T).

Authors:  Iliatha Papachristou Nadal; Chanchanok Aramrat; Wichuda Jiraporncharoen; Kanokporn Pinyopornpanish; Nutchar Wiwatkunupakarn; Orawan Quansri; Kittipan Rerkasem; Supattra Srivanichakorn; Win Techakehakij; Nutchanath Wichit; Chanapat Pateekhum; Nick Birk; Elisha Ngetich; Kamlesh Khunti; Kara Hanson; Sanjay Kinra; Chaisiri Angkurawaranon
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 2.692

5.  The Chinese version of the revised Diabetes Distress Scale for adults with type 2 diabetes: Translation and validation study.

Authors:  Yu-Yun Zhang; Wei Li; Yu Sheng
Journal:  Int J Nurs Sci       Date:  2022-03-08

6.  Prevalence and Associated Factors of Diabetes Distress, Depression and Anxiety Among Primary Care Patients With Type 2 Diabetes During the COVID-19 Pandemic in Egypt: A Cross-Sectional Study.

Authors:  Hazem A Sayed Ahmed; Ahmed Mahmoud Fouad; Sally Fawzy Elotla; Anwar I Joudeh; Mona Mostafa; Asghar Shah; Jaffer Shah; Samar F Mohamed
Journal:  Front Psychiatry       Date:  2022-06-03       Impact factor: 5.435

7.  Factors Associated with Diabetes-Related Distress in Type 2 Diabetes Mellitus Patients.

Authors:  Gilang Bhaskara; Anak Agung Gde Budhiarta; Wira Gotera; Made Ratna Saraswati; I Made Pande Dwipayana; I Made Siswadi Semadi; Ida Bagus Aditya Nugraha; Ida Ayu Kusuma Wardani; Ketut Suastika
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-15       Impact factor: 3.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.